The HAVCR2 gene helps your body put brakes on parts of the immune system so inflammation stays under control after immune cells have done their job. If this gene does not work properly, immune cells may stay too active and drive ongoing inflammation. Some people with damaging variants in the HAVCR2 gene develop rare conditions with fever, enlarged liver or spleen, low blood counts, or a rare T cell lymphoma. In medicine, this gene is important because it helps regulate immune balance.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the information needed to produce proteins, the parts of cells that do much of the work. Others mainly guide when certain processes take place, where they happen, and how strongly they are carried out. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can visit the LearnHub.
Overview
HAVCR2Gene function
What if the gene works
The HAVCR2 gene helps make TIM-3, a protein on immune cells. It helps keep immune responses in check, especially during ongoing inflammation, so the body does not stay overly activated.
Risk
What if the gene does not work
Variants in the HAVCR2 gene can impair immune control and are linked to a rare condition with painful skin lumps, fever, and immune overactivation. Milder and more severe variants can influence when it appears and how intense symptoms become.
Treatment
What does that mean for your treatment
No treatment or management approach is currently established specifically for pathogenic variants in the HAVCR2 gene. In research, the HAVCR2 gene product TIM-3 is being studied as an immune checkpoint target, a signal that can tune immune activity, and as a biomarker in some cancers and inflammatory conditions.
Conditions associated with HAVCR2
Gene function
What if the gene works
Many immune responses need a built in brake so they settle down at the right time. The HAVCR2 gene makes TIM-3, a surface protein that helps immune cells read slow-down signals. Understanding how the HAVCR2 gene works in the immune system helps explain how your body balances defense with calm, healthy tissues.
This gene helps activated immune cells slow down when a response has done its job. That supports a more controlled reaction and helps limit unnecessary inflammation.
On T cells, its protein fine-tunes signals that shape how strongly these cells respond. This helps immune activity stay better matched to the situation instead of remaining fully switched on.
Its protein can recognize phosphatidylserine (a signal on dying cells). This helps immune cells notice material that should be cleared away as tissues renew and heal.
In natural killer cells and some other immune cells, HAVCR2 helps tune cell-to-cell signaling and the release of immune messengers. That supports a coordinated response across the immune system.
What is a variant?
Small differences in a gene’s DNA sequence are called genetic variants. They are common and help shape normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. In some situations, however, a variant can change gene function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many HAVCR2 gene variants change the TIM-3 protein so it folds poorly, gets trapped inside the cell, or reaches the cell surface in lower amounts. This shows how HAVCR2 gene variants affect protein function by reducing TIM-3 activity in immune cells. Milder variants may leave some activity, while more severe variants can cause a greater loss. In the best-known HAVCR2 linked immune condition, that larger loss may be tied to earlier or stronger symptoms.
How variants are linked to conditions
Pathogenic variants in the HAVCR2 gene can cause a rare inherited condition that often appears as subcutaneous panniculitis-like T-cell lymphoma, a lymphoma affecting fatty tissue under the skin, sometimes with hemophagocytic lymphohistiocytosis, an intense inflammatory reaction. In medical genetics, HAVCR2 gene variants linked to conditions are most strongly connected to this pattern rather than to common illnesses. People may develop painful skin nodules, fever, enlarged liver or spleen, low blood counts, or ongoing inflammation.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely seen in the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well characterized variant in a specific gene can by itself confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce risk related to the HAVCR2 gene. In families with a disease-causing HAVCR2 change, risk is mainly linked to the inherited variant itself, and a doctor or genetic counselor can help explain what that may mean for you.
Inheritance of HAVCR2 variants
HAVCR2-related conditions that are clearly linked to inherited gene changes are usually passed down in an autosomal recessive pattern. This means a person inherits one HAVCR2 gene variant from each parent, and parents who each carry one variant are often unaffected themselves. For each pregnancy, two carrier parents have a 25% chance of having a child with the condition, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no inherited variant in the HAVCR2 gene. This is the main answer to how HAVCR2 gene variants are inherited in families.
What does my HAVCR2 result mean for my family?
For HAVCR2, the clearest family pattern is recessive. This usually means parents can be healthy carriers, while brothers and sisters may either have the same gene change or be carriers too. For many families, close relatives may want to learn whether the result runs in the family, especially if there is a history of severe immune problems, unexplained inflammation, or a related blood cancer.
Genetic information
Genetic testing
How you find out about variants
HAVCR2 genetic testing usually uses a blood or saliva sample to read the HAVCR2 gene and look for variants. It can help show whether you carry a variant linked to certain inherited immune conditions, and results are interpreted alongside your symptoms, personal history, and family history.
When should I consider getting a genetic test?
Genetic testing for the HAVCR2 gene may be worth considering if you or a close relative has had a rare severe immune overreaction with ongoing fevers, low blood counts, and organ inflammation, or a rare lymphoma that starts in the fatty layer under the skin. It can help explain the cause and show whether the change runs in the family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, how much of it reaches the bloodstream, or how strongly the body responds to it, so the same treatment may work differently from one person to another. These differences are common and can influence how helpful a medicine is or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences can shape the way a person responds to medicines. By studying links between genes and medications, it helps explain why the same treatment may affect people in different ways. For many drugs, genes influence either how strongly the medicine works or how the body handles it. This information can support more informed, individualized treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the HAVCR2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about treatment effects, side effects, or medicine changes are best discussed with your doctor. HAVCR2 is being studied in cancer research because it helps control immune responses and may influence how some people respond to immune-based treatments, but this has not become routine part of care.
History
The HAVCR2 gene entered the research literature in the early 2000s, when scientists studying immune cell signaling identified the protein now widely known as TIM-3. Early work first drew attention to its role in T cells, and that helped place the gene within a growing area of immunology research. From these first observations, research expanded steadily. As cancer immunotherapy advanced, interest in the HAVCR2 gene grew because it became part of the broader story of immune checkpoint biology. In later years, inherited variants in the HAVCR2 gene were also linked to rare inflammatory and blood related conditions, which gave the gene added clinical importance. Today, its history reflects how a gene can move from laboratory discovery to wider medical relevance.